COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE— 510(k) K020920
Substantially EquivalentCozart Bioscience , Ltd.
FDA 510(k) clearance K020920 for COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE, Substantially Equivalent on 2002-11-05. Applicant: Cozart Bioscience , Ltd..
Clearance details
- Applicant
- Cozart Bioscience , Ltd.
- Product code
- Code DJG
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Oxfordshire Ox14 4ru, GB
Data sourced from openFDA. This site is unofficial and independent of the FDA.